London, Canada
ADEISS is a Canadian company leading the development of customized, bio-compatible, 3D printed medical devices. Founded in 2016 and based in London, Ontario, Canada, ADEISS aims to revolutionize the provision of medical devices by leveraging 3D printing technology to create precise, bio-compatible, metal 3D-printed medical devices for improved patient care at a lower cost. The company's product portfolio includes surgical instruments and cutting guides, implants, and external prosthetics, all of which are customized to the client’s complex geometric requirements and unique anatomy.
ADEISS's innovative approach allows for faster, more cost-effective production with fewer residual impacts compared to traditional methods, ultimately contributing to an enhanced patient experience and the betterment of the healthcare system. The company is currently pursuing ISO 13485 accreditation and certifications in the United States, Canada, and Europe.
With its focus on manufacturing and the potential to disrupt the medical device industry, ADEISS presents an intriguing investment opportunity for venture capitalists seeking to support cutting-edge technology with the potential to significantly impact the healthcare sector.
